Polidocanol - BTG
Alternative Names: PEM; Polidocanol Endovenous Microfoam; Polidocanol injectable foam; Varisolve PEM; Varisolve®; VarithenaLatest Information Update: 17 Dec 2021
At a glance
- Originator BTG
- Developer BTG; BTG International
- Class Obesity therapies; Polyethylene glycols; Sclerosants; Small molecules; Vascular disorder therapies
- Mechanism of Action Endothelial cell modulators; Vascular disrupting agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Varicose veins
Highest Development Phases
- Marketed Varicose veins